Literature DB >> 6612173

A fibroblast mitogen present in scleroderma but not control sera: inhibition by proteinase inhibitors.

E C LeRoy, M B Kahaleh, S Mercurio.   

Abstract

Fibroblast mitogenic activity (MA) has been identified in scleroderma (SD) sera. Control and scleroderma skin fibroblasts in early passage were observed for replication (cell counts) after 72 h of serum exposure. SD sera at 15% concentration induced a significant increase in control fibroblast numbers when compared with control sera; this effect was not seen with SD cells while at higher serum concentrations (30%); SD cells were slightly responsive to the MA. MA was completely abrogated by the proteinase inhibitors STI and TLCK which did not affect mitogens in healthy sera. Circulating mitogenic proteinases selective for fibroblasts could play a role in the fibrosis of SD by modulating fibroblast replication.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6612173     DOI: 10.1007/bf00541230

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  7 in total

1.  Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast.

Authors:  E C LeRoy
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

2.  Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors.

Authors:  E C LeRoy; S Mercurio; G K Sherer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

3.  Human monocyte stimulation of fibroblast growth by a soluble mediator(s).

Authors:  F DeLustro; G K Sherer; E C LeRoy
Journal:  J Reticuloendothel Soc       Date:  1980-12

4.  Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.

Authors:  J Uitto; E A Bauer; A Z Eisen
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

5.  Fibroblast selection in scleroderma. An alternative model of fibrosis.

Authors:  G R Botstein; G K Sherer; E C Leroy
Journal:  Arthritis Rheum       Date:  1982-02

6.  Connective tissue synthesis by scleroderma skin fibroblasts in cell culture.

Authors:  E C Leroy
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

7.  Endothelial injury in scleroderma.

Authors:  M B Kahaleh; G K Sherer; E C LeRoy
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

  7 in total
  3 in total

1.  Response of scleroderma fibroblasts to various growth factors.

Authors:  K Takehara; Y Soma; A Igarashi; K Kikuchi; A Moro; Y Ishibashi
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Mitogenic activities for skin fibroblasts in the sera from untreated scleroderma patients at the early stage.

Authors:  A Igarashi; K Takehara; Y Soma; K Kikuchi; Y Ishibashi
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 3.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.